ImmuCell Corporation Interest Expense 2011-2026 | ICCC

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense ImmuCell Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	349 K	314 K	348 K	-314 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
349 K	-314 K	174 K

Quarterly Interest Expense ImmuCell Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	144 K	142 K	146 K	-	145 K	88.6 K	90 K	-	89.4 K	90.2 K	75.2 K	-	78.5 K	79.4 K	79.6 K	-	-71.3 K	-74.5 K	-334 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
146 K	-334 K	51.2 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	9.34 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	23 K	$ 19.14	0.74 %	$ 895 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.63	3.5 %	$ 434 M	Britain
I-Mab IMAB	722 K	-	-	$ 866 M	China
BioNTech SE BNTX	14.2 M	$ 94.9	0.82 %	$ 22.9 B	Germany
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Athira Pharma ATHA	1.24 M	-	-	$ 269 M	USA
Esperion Therapeutics ESPR	3.49 M	$ 3.13	-0.48 %	$ 651 M	USA
Exelixis EXEL	-198 K	$ 49.35	2.47 %	$ 13.4 B	USA
Fortress Biotech FBIO	17.6 M	$ 2.36	-1.26 %	$ 65.8 M	USA
Forte Biosciences FBRX	-396 K	$ 24.9	3.65 %	$ 322 M	USA
AbbVie ABBV	2.89 B	$ 203.32	0.97 %	$ 360 B	USA
Gilead Sciences GILD	-1 M	$ 133.2	1.42 %	$ 166 B	USA
Compugen Ltd. CGEN	281 K	$ 2.82	-2.76 %	$ 263 M	Israel
Enlivex Therapeutics Ltd. ENLV	1.93 M	$ 0.77	0.16 %	$ 35.2 M	Israel
ACADIA Pharmaceuticals ACAD	1.82 M	$ 22.41	0.04 %	$ 3.71 B	USA
Genprex GNPX	38 K	$ 0.85	-1.99 %	$ 793 K	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 3.46	-1.98 %	$ 5.7 M	Israel
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 21.09	-0.4 %	$ 2.68 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA